Vivos Therapeutics, Inc. (VVOS)
Nasdaq: VVOS · Surgical & Medical Instruments & Apparatus · Littleton, CO · filing with the SEC since 2017
Who owns Vivos Therapeutics, Inc.
As filed with the SECHolders of 5% or more
4
SP Manager LLC holds 19.9% of Common Stock, par value $0.0001 per share, as its SCHEDULE 13D filed Jul 15, 2026 says.
Directors and officers
7
report now, of 9 people on the record since 2020. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
SP Manager LLC
SCHEDULE 13D · filed Jul 15, 2026 · Common Stock, par value $0.0001 per share
SP Manager LLC
SCHEDULE 13D · filed Apr 2, 2026 · Common Stock, par value $0.0001 per share
SP Manager LLC
SCHEDULE 13D · filed Jun 16, 2025 · Common Stock, par value $0.0001 per share · 9.9% in Dec 20, 2024
Dawei Luo
SCHEDULE 13G · filed Jul 14, 2025 · Common stock, par value $0.0001 per share
Armistice Capital, LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 8.27% in May 15, 2026
Mitchell P. Kopin
SCHEDULE 13G · filed Dec 30, 2024 · Common stock, par value $0.0001 per share · reported falling below 5%
Streeterville Capital LLC
SCHEDULE 13G/A · filed Sep 3, 2026 · Common stock, par value $0.0001 per share · reported falling below 5%, from 9.3% in Aug 11, 2026
What VVOS reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
V-Co Investors 3 LLC
An entity · legal entity · owns, named in the 10-K filed Apr 15, 2026
The Sleep Center of Nevada
A company bought · acquisition · May 2025 · owns, named in the 10-K filed Apr 15, 2026
16 subsidiaries in 2 countries, from the list filed with the 10-K filed Apr 15, 2026.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 27, 2025 to Oct 27, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2023 runs to Oct 27, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 12 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| V-Co Investors 3 LLC | 10% owner | 0 | $0 | 0 | 2 | $1.8M |